How a specific enzyme controls the length of bacterial polysaccharides
Enzymatic Mechanism of Polysaccharide Length Control by GlfT2
This study is looking at how a specific enzyme called GlfT2 helps bacteria make important sugar chains that affect their survival and how they respond to antibiotics, which could help us find new ways to fight bacterial infections.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts Institute of Technology NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project ID | NIH-10909396 on NIH RePORTER |
What this research studies
This research investigates the role of the enzyme GlfT2 in controlling the length of polysaccharides produced by bacteria, which are crucial for their survival and interaction with the environment. By understanding the enzymatic mechanisms involved in polysaccharide biosynthesis, the research aims to uncover how these processes affect bacterial fitness and antibiotic susceptibility. The study will utilize biochemical assays and genetic techniques to analyze the function of GlfT2 and its impact on the structure of bacterial cell walls. Insights gained could lead to new strategies for combating bacterial infections.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with infections caused by antibiotic-resistant bacteria, particularly those involving Mycobacterium species.
Not a fit: Patients with infections caused by non-bacterial pathogens or those not affected by antibiotic resistance may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for bacterial infections by targeting the mechanisms that enhance antibiotic resistance.
How similar studies have performed: Other research has shown promising results in understanding bacterial polysaccharide biosynthesis, indicating that this approach has potential for significant advancements.
Where this research is happening
Cambridge, United States
- Massachusetts Institute of Technology — Cambridge, United States (Active)
Researchers
- Principal investigator: Carter, Alan Wylde — Massachusetts Institute of Technology
- Study coordinator: Carter, Alan Wylde
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.